Cyclacel Pharma (CYCC) Reports Q1 Loss of $0.38
Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.38), versus $1.04 reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.38), versus $1.04 reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.